2019
Ascites-Derived Extracellular microRNAs as Potential Biomarkers for Ovarian Cancer
ZÁVESKÝ, Luděk, Eva JANDÁKOVÁ, Vít WEINBERGER, Luboš MINÁŘ, Veronika HANZÍKOVÁ et. al.Základní údaje
Originální název
Ascites-Derived Extracellular microRNAs as Potential Biomarkers for Ovarian Cancer
Autoři
ZÁVESKÝ, Luděk (203 Česká republika, garant), Eva JANDÁKOVÁ (203 Česká republika), Vít WEINBERGER (203 Česká republika, domácí), Luboš MINÁŘ (203 Česká republika, domácí), Veronika HANZÍKOVÁ (203 Česká republika), Daniela DUŠKOVÁ (203 Česká republika), Lenka ZÁVESKÁ DRÁBKOVÁ (203 Česká republika), Iveta SVOBODOVÁ (203 Česká republika) a Aleš HOŘÍNEK (203 Česká republika)
Vydání
REPRODUCTIVE SCIENCES, THOUSAND OAKS, SAGE PUBLICATIONS INC, 2019, 1933-7191
Další údaje
Jazyk
angličtina
Typ výsledku
Článek v odborném periodiku
Obor
30214 Obstetrics and gynaecology
Stát vydavatele
Spojené státy
Utajení
není předmětem státního či obchodního tajemství
Odkazy
Impakt faktor
Impact factor: 2.616
Kód RIV
RIV/00216224:14110/19:00109661
Organizační jednotka
Lékařská fakulta
UT WoS
000461442500009
Klíčová slova anglicky
ovarian cancer; ascites; microRNA; diagnostic markers; prognostic markers
Příznaky
Mezinárodní význam, Recenzováno
Změněno: 16. 5. 2019 12:01, Soňa Böhmová
Anotace
V originále
Ovarian cancer as the most fatal gynecological malignancy is often manifested by excessive fluid accumulation known as ascites or effusion. Ascites-derived microRNAs (miRNAs) may be closely associated with ovarian cancer progression. However, our knowledge of their roles, altered expression, and clinical outcomes remained limited. In this study, large-scale expression profiling of 754 human miRNAs was performed using real-time quantitative polymerase chain reaction and 384-well TaqMan array human miRNA A and B cards to identify differentially expressed miRNAs between extracellular fraction of the ascitic fluid associated with high-grade serous ovarian carcinomas and control plasma. Of the 754 miRNAs, 153 were significantly differentially expressed relative to the controls. Expression of 7 individual miRNAs (miR-200a, miR-200b, miR-200c, miR-141, miR-429, miR-1290, and miR-30a-5p) was further validated in extended sample sets, including serous, endometrioid, and mucinous subtypes. All miR-200 family members and miR-1290 were conspicuously overexpressed, while miR-30a-5p was only weakly overexpressed. The ability of miRNAs expression to discriminate the pathological samples from the controls was strong. Receiver operating characteristic curve analyses found area under the curve (AUC) values of 1.000 for miR-200a, miR-200c, miR-141, miR-429, and miR-1290 and of AUC 0.996 and 0.885 for miR-200b and miR-30a-5p, respectively. Preliminary survival analyses indicated low expression level of miR-200b as significantly related to longer overall survival (hazard ratio [HR]: 0.25, mean survival 44 months), while high expression level was related to poor overall survival (HR: 4.04, mean survival 24 months). Our findings suggested that ascites-derived miRNAs should be further explored and evaluated as potential diagnostic and prognostic biomarkers for ovarian cancer.